Skip to main content

Current Pharmacological Treatment of Osteoarthritis

Drugs volume 52, pages 27–38 (1996)Cite this article

Summary

In this overview, the currently available symptomatic treatments of osteoarthritis from the published literature are evaluated. Paracetamol attracts growing interest as a less toxic yet potent alternative to NSAIDs. These latter agents are, however, used more widely than paracetamol, although adverse reactions associated with their use are of increasing concern among both patients and physicians. New NSAIDs are still under development. While there is not much evidence of important differences between NSAIDs in overall efficacy, they do vary with regard to toxicity. The cytoprotective effect of misoprostol in at-risk patients on NSAIDs is established but the cost-effectiveness is unclear. Furthermore, percutaneous administration of NSAIDs, capsaicin, and other substances may have some merit. Opioids, such as dextropropoxyphene, are used in combination with paracetamol in patients intolerant to NSAIDs or when pain is not controlled with NSAIDs. Locally administered glucocorticoids may have a disease-modifying effect and are of symptomatic use in certain situations. The role, if any, of hyaluronan therapy remains to be established. Although this agent appears to have a good safety profile, it is expensive. Chondroprotection is an interesting field for future research, although there is no good evidence supporting its existence in clinical medicine as practised now.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

49,54 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Bergenudd H, Johnell O, Redlund-Johnell I, et al. The articular cartilage after osteotomy for medial gonarthrosis. Biopsies after 2 years in 19 cases. Acta Orthop Scand 1992; 63: 413–6.

    PubMed  Article  CAS  Google Scholar 

  2. Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham study. Ann Int Med 1992; 116: 535–9.

    PubMed  CAS  Google Scholar 

  3. Falconer J, Hayes KW, Chang RW. Therapeutic ultrasound in the treatment of musculoskeletal conditions. Arthritis Care Res 1990; 3: 85–91.

    PubMed  CAS  Google Scholar 

  4. Lewis D, Lewis B, Sturrock RD. Transcutaneous electrical nerve stimulation in osteoarthritis: a therapeutic alternative? Ann Rheum Dis 1984; 43: 47–9

    PubMed  Article  CAS  Google Scholar 

  5. Puett DW, Griffin MR. Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis. Ann Intern Med 1994; 121: 133–40.

    PubMed  CAS  Google Scholar 

  6. René J, Weinberger M, Mazzuca SA, et al. Reduction of joint pain in patients with knee osteoarthritis who have received monthly telephone calls from lay personnel and whose medical treatment regimens have remained stable. Arthritis Rheum 1992; 35: 511–5.

    PubMed  Article  Google Scholar 

  7. Bradley JD, Brandt KD, Katz BP, et al. Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991; 325: 87–91.

    PubMed  Article  CAS  Google Scholar 

  8. Williams JH, Ward JR, Egger MJ, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993; 36: 1196–206.

    PubMed  Article  CAS  Google Scholar 

  9. Kjaersgaard-Andersson P, Nafei A, Skov O, et al. Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study. Pain 1990; 43: 309–18.

    Article  Google Scholar 

  10. Seidemann P, Samuelson P, Neander G. Naproxen and paracetamol compared with naproxen only in coxarthrosis. Increased effect of the combination in 18 patients. Acta Orthop Scand 1993; 64: 285–8.

    Article  Google Scholar 

  11. Sandier DP, Smith JC, Weinberg CR, et al. Analgesic use and chronic renal failure. N Engl J Med 1989; 320: 1238–43.

    Article  Google Scholar 

  12. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin and non-steroidal antiinflammatory drugs. N Engl J Med 1994; 331: 1675–9.

    PubMed  Article  CAS  Google Scholar 

  13. Orme ML. The relationship between plasma concentration of nonsteroidal anti-inflammatory drugs and their therapeutic effects. Agents Actions 1988; 17 Suppl.: 151–5.

    Google Scholar 

  14. Brooks PM, Day RO. Nonsteroidal anti-inflammatory drugs — differences and similarities. N Engl J Med 1991; 324: 1716–25.

    PubMed  Article  CAS  Google Scholar 

  15. Sirois J, Richards JAS. Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles. J Biol Chem 1992; 267: 6382–8.

    PubMed  CAS  Google Scholar 

  16. Meade EA, Smith WI, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other nonsteroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610–4.

    PubMed  CAS  Google Scholar 

  17. Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cycloxygenase. Proc Natl Acad Sci USA 1994; 90: 11693–7.

    Article  Google Scholar 

  18. Pairet M, Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam Clin Pharmacol 1996; 10: 1–15.

    PubMed  Article  CAS  Google Scholar 

  19. Scheja A, Forsgren A, Marsal L, et al. Inhibition of in vivo leucocyte migration by NSAIDs. Clin Exp Rheumatol 1985; 3: 53–8.

    PubMed  CAS  Google Scholar 

  20. Rosenstein ED, Kunicka J, Kramer N, et al. Modification of cytokine production by piroxicam. J Rheumatol 1994; 21: 901–4.

    PubMed  CAS  Google Scholar 

  21. Gonzales E, de la Cruz C, de Nicolas R, et al. Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions 1994; 41: 171–8.

    Article  Google Scholar 

  22. Rainsford KD. Mechanisms of NSAIDs on joint destruction in osteoarthritis. Agents Actions (Suppl.) 1993; 44: 39–43.

    CAS  Google Scholar 

  23. Carroll GJ, Bell MC, Laing BA, et al. Reduction of the concentration and total amount of keratan sulphate in synovial fluid from patients with osteoarthritis during treatment with piroxicam. Ann Rheum Dis 1992; 51: 850–4.

    PubMed  Article  CAS  Google Scholar 

  24. G0tzsche PC. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Contr Clin Trials 1989; 10: 31–56.

    Article  CAS  Google Scholar 

  25. Furst DE. Are there differences among nonsteroidal anti-inflammatory drugs? Arthritis Rheum 1994; 37: 1–9

    PubMed  Article  CAS  Google Scholar 

  26. Ersmark H, Tjornstrand B, Gudmundsson G, et al. Piroxicam and indometacin suppositories for painful coxarthrosis. Clin Rheumatol 1992; 11: 37–40.

    PubMed  Article  CAS  Google Scholar 

  27. Caldwell JR, Roth SH. A double blind study comparing the efficacy and safety of enteric coated naproxen to naprpxen in the management of NSAID intolerant patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1994; 21: 689–95.

    PubMed  CAS  Google Scholar 

  28. Hoyeraal HM, Fagertun H, Ingemann-Hansen T, et al. Characterization of responders and nonresponders to tiaprofenic acid and naproxen in the treatment of patients with osteoarthritis. J Rheumatol 1993; 20: 1747–52.

    PubMed  CAS  Google Scholar 

  29. Melo Gomes JA, Roth SH, Zeeh J, et al. Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis. Ann Rheum Dis 1993; 52: 881–5.

    PubMed  Article  CAS  Google Scholar 

  30. Riedemann PJ, Bersinic S, Cuddy LJ, et al. A study to determine the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in patients with osteoarthritis: a meta-analysis. J Rheumatol 1993; 20: 2095–103.

    PubMed  CAS  Google Scholar 

  31. Bellamy N, Buchanan WW, Chalmers A, et al. A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the knee. J Rheumatol 1993; 20: 999–1004.

    PubMed  CAS  Google Scholar 

  32. Roth SH, Bennett R, Caldron P, et al. A longterm endoscopic evaluation of patients with arthritis treated with nabumetone vs naproxen. J Rheumatol 1994; 21: 1118–23.

    PubMed  CAS  Google Scholar 

  33. Chikanza IC, Clarke B, Hopkins R, et al. A comparative study of the efficacy and toxicity of etodolac and naproxen in the treatment of osteoarthritis. Br J Clin Pract 1994; 48: 67–9.

    PubMed  CAS  Google Scholar 

  34. Nguyen M, Dougados M, Berdah L, et al. Diacerhein in the treatment of osteoarthritis of the hip. Arthritis Rheum 1994; 37: 529–36.

    PubMed  Article  CAS  Google Scholar 

  35. Ahmed M, Davison OW. Severe cystitis associated with tiaprofenic acid. BMJ 1991; 303: 1376.

    PubMed  Article  CAS  Google Scholar 

  36. Ghosh P, Armstrong S, Read R, et al. Animal models of early osteoarthritis: their use for the evaluation of potential chondroprotective agents. Agents Actions 1993; Suppl. 39: 195–206

    Article  CAS  Google Scholar 

  37. Harrison WJ, Willis RG, Neal DE. Adverse reactions to tiaprofenic acid mimicking interstitial cystitis. BMJ 1994; 309: 574.

    PubMed  Article  CAS  Google Scholar 

  38. Mayall FG, Blewitt RW, Staff WG. Cystitis and ureteric obstruction in patients taking tiaprofenic acid. BMJ 1994; 309: 599–600.

    PubMed  Article  CAS  Google Scholar 

  39. Murray MD, Brater DC. Renal toxicity of the nonsteroidal anti-inflammatory drugs. Ann Rev Pharmacol Toxicol 1993; 32: 435–65.

    Google Scholar 

  40. DuBose Jr TD. Grand round. Nephrotoxicity of non-steroidal anti-inflammatory drugs. Lancet 1994; 344: 515–8.

    Article  Google Scholar 

  41. Lanza FL. Gastrointestinal toxicity of newer NSAIDs. Am J Gastroenterol 1993; 88: 1318–23.

    PubMed  CAS  Google Scholar 

  42. Bateman DN. NSAIDs: time to re-evaluate gut toxicity. Lancet 1994; 343: 1051–2.

    PubMed  Article  CAS  Google Scholar 

  43. Paulus HE. Aspirin versus nonacetylated salicylate [editorial]. J Rheumatol 1989; 16: 264–5.

    PubMed  CAS  Google Scholar 

  44. Bolton W, MeloGomes JA, Stead H, et al. The gastroduodenal safety and efficacy of the fixed combination of diclofenac and misoprostol in the treatment of osteoarthritis. Br J Rheumatol 1992; 31: 753–8.

    Article  Google Scholar 

  45. Kiff PS, Stead H, Morant SV, et al. Arthrotec, diclofenac and ibuprofen in general practice. Eur J Rheumatol 1994; 14: 31–7.

    CAS  Google Scholar 

  46. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med 1995; 123: 241–9.

    PubMed  CAS  Google Scholar 

  47. Boissier C, Perpoint B, Laporte-Simitsidis S, et al. Acceptability and efficacy of two associations of paracetamol with a central analgesic (dextropropoxyphene or codeine): comparison in osteoarthritis. J Clin Pharmacol 1992; 32: 990–5.

    PubMed  CAS  Google Scholar 

  48. Lloyd RS, Costello F, Eves MJ, et al. The efficacy and tolerability of controlled-release dihydrocodeine tablets and combination dextropropoxyphene/paracetamol tablets in patients with severe osteoarthritis of the hips. Curr Med Res Opin 1992; 13: 37–48.

    PubMed  Article  CAS  Google Scholar 

  49. Jensen EM, Ginsberg F. Tramadol versus dextropropoxyphene in the treatment of osteoarthritis. A short term double-blind study. Drug Invest 1994; 8: 211–8.

    Article  Google Scholar 

  50. Pavelka K. Functional outcome and joint pain is improved in osteoarthritis patients receiving an NSAID or a centrally acting analgesic. Ann Rheum Dis. In press

  51. Roth SF. Safety and efficacy of tramadol HC1 in breakthrough osteoarthritis pain [abstract E73]. EULAR 1995; 24 Suppl. 3: 331.

    Google Scholar 

  52. Neuman M. Clinical, biological and gastric fibroscopic tolerance of a new nonsteroidal anti-inflammatory analgesic, diacerhein (Artrodar). Drugs Exp Clin Res 1980; 6: 53–64.

    Google Scholar 

  53. Mazieres B, Berdah L. Effect of diacerhein (ART50) on an experimental postcontusive model of osteoarthritis [abstract]. Osteoarthritis Cartilage 1993; 1: 47.

    Google Scholar 

  54. Pujol JP. Collagenolytic enzymes and interleukine 1: their role in inflammation and cartilage degradation; the antagonistic effects of diacerhein on IL-1 action on cartilage matrix components [abstract]. Osteoarthritis Cartilage 1993; 1: 82.

    Google Scholar 

  55. Gallacchi G, Marcolongo R. Pharmacokinetics of diclofenac hydroxyethylpyrrolidine (DHEP) plasters in patients with monolateral knee jont effusion. Drugs Exp Clin Res 1993; 19: 95–7.

    PubMed  CAS  Google Scholar 

  56. Fargas-Babjak AM, Pomeranz B, Rooney PJ. Acupuncture-like stimulation with codtron for rehabilitation of patients with chronic pain syndrome and osteoarthritis. Acupunct Electrother Res 1992; 17: 95–105.

    PubMed  CAS  Google Scholar 

  57. Taylor P, Hallet M, Flaherty L. Treatment of osteoarthritis of the knee with transcutaneous electrical nerve stimulation. Pain 1981; 11: 233–41.

    PubMed  Article  CAS  Google Scholar 

  58. Lewis B, Lewis D, Cumming G. The comparative analgesic efficacy of transcutaneous electrical nerve stimulation and a non-steroidal anti-inflammatory drug for painful osteoarthritis. Br J Rheumatol 1994; 33: 455–60.

    PubMed  Article  CAS  Google Scholar 

  59. Virus RM, Gebhart GF. Pharmacologic actions of capsaicin: apparent involvement of substance P and serotonin. Life Science 1979; 25: 1273–84.

    Article  CAS  Google Scholar 

  60. McCarty GM, McCarthy DJ. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol 1992; 19: 604–7.

    PubMed  Google Scholar 

  61. Zhang WY, Li Wan Po A. The effectiveness of topically applied capsaicin. A meta-analysis. Eur J Clin Pharmacol 1994; 46: 517–22.

    PubMed  Article  CAS  Google Scholar 

  62. Shuster S. Capsaicin and the cause of causalgia. Lancet 1994; 345: 160–1.

    Article  Google Scholar 

  63. Bendrups A, Hilton A, Meager A, et al. Reduction of tumor necrosis factor alpha and interleukin-1 beta levels in human synovial tissue by interleukin-4 and glucocorticoid. Rheumatol Int 1993; 12: 217–20.

    PubMed  Article  CAS  Google Scholar 

  64. Friedman DM, Moore ME. The efficacy of intra-articular steroids in OLA: a double-blind study. J Rheumatol 1980; 7: 850–6.

    PubMed  CAS  Google Scholar 

  65. Dieppe PA, Sathapatayavons B, Jones HE, et al. Intra-articular steroids in osteoarthritis. Rheumatol Rehabil 1980; 19: 212–7.

    PubMed  Article  CAS  Google Scholar 

  66. Sheeran TP, Roobottom CA, Wanklyn PD, et al. The effect of bed rest and intra-articular steroids on the acute phase response in rheumatoid arthritis. Clin Exp Rheumatol 1993; 11: 49–52.

    PubMed  CAS  Google Scholar 

  67. Valtonen EJ. Clinical comparison of triamcinolonehexacetonide and betamethasone in the treatment of osteoarthrosis of the knee-joint. Scand J Rheumatol 1981; Suppl. 41: 1–7

    CAS  Google Scholar 

  68. Blyth T, Hunter JA, Stirling A. Pain relief in the rheumatoid knee after steroid injection, a single blind comparison of hydrocortisone succinate, and triamcinolone acetonide or hexcetonide. Br J Rheumatol 1994; 33: 461–3.

    PubMed  Article  CAS  Google Scholar 

  69. Jones A, Regan M, Ledingham J, et al. Importance of placement of intra-articular steroid injections. BMJ 1993; 307: 1329–30.

    PubMed  Article  CAS  Google Scholar 

  70. Ike RW, Arnold WJ, Rothschild EW, et al. Tidal irrigation versus conservative medical management in patients with osteoarthritis of the knee: a prospective randomized study. J Rheumatol 1992; 19: 772–9.

    PubMed  CAS  Google Scholar 

  71. Östensson A, Geborek P. Septic arthritis as a nonsurgical complication in rheumatoid arthritis: relation to disease severity and therapy. Br J Rheumatol 1991; 30: 35–8.

    PubMed  Article  Google Scholar 

  72. Goa KL, Benfield P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs 1994; 47: 536–66.

    PubMed  Article  CAS  Google Scholar 

  73. Abatangelo G, Botti P, Del Bue M, et al. Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. I. Biochemical results. Clin Orthop 1989; 241: 278–83.

    PubMed  Google Scholar 

  74. Schiavinato A, Lini E, Giudolin D, et al. Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II. Morphological findings. Clin Orthop 1989; 241: 286–99.

    PubMed  Google Scholar 

  75. Creamer P, Sharif M, George E, et al. Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis Cartilage 1994; 2: 133–40.

    PubMed  Article  CAS  Google Scholar 

  76. Puhl W, Bernau A, Greiling H, et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthritis Cartilage 1993; 1: 233–41.

    PubMed  Article  CAS  Google Scholar 

  77. Dougados M, Nguyen M, Listra V, et al. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1993; 1: 97–103.

    PubMed  Article  CAS  Google Scholar 

  78. Dahlberg L, Lohmander LS, Ryd L. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. A one-year double-blind, placebo-controlled study. Arthritis Rheum 1994; 37: 521–8.

    PubMed  Article  CAS  Google Scholar 

  79. Hendersson EB, Smith EC, Pegley F, et al. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis 1994; 53: 529–34.

    Article  Google Scholar 

  80. Adams ME. An analysis of clinical studies of the use of cross-linked hyaluronan, hylan, in the treatment of osteoarthritis. J Rheumatol 1993; 20 Suppl. 39: 16–8.

    Google Scholar 

  81. Lohmander LS. A controlled randomised, double-blind multi-center trial of intra-articular hyaluron treatment in osteoarthrosis of the knee. Acta Orthop Scand 1995; 66 Suppl. 265: 35–6.

    Google Scholar 

  82. Moskowitz RW, Reese JH, Young RG, et al. The effects of Rumalon, a glycosaminoglycan peptide complex, in a partial meniscectomy model of osteoarthritis in rabbits. J Rheumatol 1991; 18: 205–9.

    PubMed  CAS  Google Scholar 

  83. Howell DS, Altman RD. Cartilage repair and conservation in osteoarthritis. A brief review of some experimental approaches to chondroprotection. Rheum Dis Clin North Am 1993; 19: 713–24.

    PubMed  CAS  Google Scholar 

  84. Francis DJ, Hutadilok N, Kongtawelert P, et al. Pentosan polysulphate and glycosaminoglycan polysulphate stimulate the synthesis of hyaluronan in vivo. Rheumatology Int 1993; 13: 61–4.

    Article  CAS  Google Scholar 

  85. McCarty MF. The neglect of glucosamine as a treatment for osteoarthritis — a personal perspective. Med Hypotheses 1994; 42: 323–7.

    PubMed  Article  CAS  Google Scholar 

  86. Baici A, Hörler D, Moser B, et al. Analysis of glucosaminoglycans in human serum after oral administration of chondroitin sulfate. Rheumatol Int 1992; 12: 81–8.

    PubMed  Article  CAS  Google Scholar 

  87. Burkhardt D, Ghosh P. Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents. Semin Arthritis Rheum 1987; 17 Suppl. 1: 3–34.

    PubMed  CAS  Google Scholar 

  88. McAlindon T, Dieppe P. The medical management of osteoarthritis of the knee: an inflammatory issue? Br J Rheumatol 1990; 29: 471–3

    PubMed  Article  CAS  Google Scholar 

  89. Berg PA, Kaboth U, Becker EW, et al. Analyse einer schweren Nebenwirkung auf ein Chondroprotektivum mit Hilfe immunologischer Untersuchungen. Deutsch Med Wochenschr 1992; 16: 1589–93.

    Article  Google Scholar 

  90. Greinacher A, Michels I, Schäfer M, et al. Heparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological cross-reactivity between heparin and polysulphated glycosaminoglycan. Br J Haematol 1992; 81: 252–4.

    PubMed  Article  CAS  Google Scholar 

  91. Noack W, Fisher M, Förster K, et al. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage 1994; 2: 51–9.

    PubMed  Article  CAS  Google Scholar 

  92. Müller-Faßbender H, Bach GL, Haase W, et al. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 1994; 2: 61–9.

    PubMed  Article  Google Scholar 

  93. Reichelt A, Förster K, Fischer M, et al. Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomized, placebo-controlled, double-blind study. Arzneimittelforschung 1994; 44: 75–80.

    PubMed  CAS  Google Scholar 

  94. Lequesne M, Brandt K, Bellamy N, et al. Guidelines for testing slow acting drugs in osteoarthritis. J Rheumatol 1994; 21 Suppl. 41: 65–71.

    Google Scholar 

  95. March L, Irwig L, Schwarz J, et al. N of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ 1994; 309: 1041–5.

    PubMed  Article  CAS  Google Scholar 

  96. Dieppe P, Cuishnahan J, Jasani MK, et al. A two-year, placebo-controlled trial of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint. Br J Rheumatol 1993; 32: 595–600.

    PubMed  Article  CAS  Google Scholar 

  97. Dexter P, Brandt K. Distribution and predictors of depressive symptoms in osteoarthritis. J Rheumatol 1994; 21: 279–86.

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Rheumatology, Lund University Hospital, S-221 85, Lund, Sweden

    Frank A. Wollheim

Authors
  1. Frank A. Wollheim
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wollheim, F.A. Current Pharmacological Treatment of Osteoarthritis. Drugs 52, 27–38 (1996). https://doi.org/10.2165/00003495-199600523-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199600523-00006

Keywords

  • Osteoarthritis
  • Paracetamol
  • Capsaicin
  • Naproxen
  • Tramadol